Disclosure: Published by AirMedFit. This is general education, not an individual treatment recommendation or a statement that a particular medicine is available through AirMedFit. Reviewed October 12, 2026.
Comparing compounded tirzepatide with Zepbound requires more than comparing an ingredient name or a monthly price. Ask your clinician to identify the exact product, why it fits your medical needs, and how its instructions and follow-up will be explained.
1. What product is being proposed?
Zepbound is an FDA-approved tirzepatide product. Compounded drugs are not FDA approved. The FDA compounding overview explains that they do not undergo the agency’s premarket review for safety, effectiveness and quality. Compounding can serve a medical need, but it does not make a product an approved generic equivalent.
Ask for the exact medicine name and formulation in writing. Record the prescriber, dispensing pharmacy, device or container and the information supplied with the prescription. Do not assume every approved presentation is a pen or that a vial automatically means a product is compounded.
2. Why is this option appropriate for me?
FDA recommends compounded GLP-1 drugs only when an FDA-approved drug cannot meet a patient’s medical needs. Ask the clinician to explain the reason for the proposed option and to discuss approved alternatives, access and coverage. A low advertised price alone does not answer the suitability question.
This guide does not establish that a specific compounder or prescription meets current federal and state requirements. Ask the prescriber and pharmacist to check the current rules for the proposed product; an older shortage-related claim is not enough. A pharmacy registration or a laboratory document is not FDA approval of its compounded product.
3. Can I understand the exact instructions?
The FDA’s current GLP-1 safety information describes concerns about dosing errors, instructions and product quality. Have the pharmacist explain the actual prescription and demonstrate the supplied device when relevant. Do not copy another patient’s syringe markings or calculate a replacement dose from an online chart.
Use a teach-back question: “Can I explain these directions in my own words so you can check that I understood them?” If the label, prescription and verbal instructions differ, resolve that discrepancy with the pharmacy and prescriber before use. Changes in concentration, packaging or devices require a fresh explanation.
4. What is the follow-up and problem plan?
Ask which warnings apply to your history, medicines, pregnancy plans and upcoming procedures. Ask what symptoms require urgent help, which can be discussed through routine follow-up, and how to reach the care team outside appointment hours. This article does not supply a personal titration schedule or a standard laboratory panel.
Before accepting a shipment, clarify the storage instructions, what to do about a damaged or temperature-compromised delivery, and whom to contact. Do not rely on a promotional guarantee as a substitute for instructions from the dispensing pharmacy.
A comparison record to take to your appointment
-
Exact product and formulation being discussed: ____
-
Reason for considering it and alternatives discussed: ____
-
Prescriber and dispensing pharmacy contact: ____
-
Written directions received and questions still unresolved: ____
-
Device demonstration or teach-back completed: ____
-
Follow-up date, urgent contact route and storage questions: ____
-
Itemized costs, what is included and renewal terms: ____
Leave unknown fields blank rather than assuming a website’s general description applies to your prescription. Keep the record with the actual label and update it if the product changes.
Preparing for a consultation
Our medical weight-loss consultation guide provides additional appointment questions. To review AirMedFit’s current service listing, visit the Doctor’s Consultation page. Confirm the service scope, clinician availability and costs directly; booking does not guarantee a prescription, eligibility or outcome.